Presenter Information

Vincent Sica, Procter & GambleFollow

Document Type

Oral Presentation

Location

Oxford Convention Center, 102 Ed Perry Boulevard Oxford, MS 38655

Event Website

https://oxfordicsb.org/

Start Date

15-4-2024 1:30 PM

End Date

15-4-2024 1:45 PM

Description

Botanicals are complex mixtures that present unique analytical challenges. A multi-detector chromatographic approach can provide accurate, constituent-based data to ensure proper identification and quantification of botanicals. These data are often used to help drive in silico safety assessments to identify suspected toxicants and assess the potential for deleterious effects using structure activity relationships. To showcase this approach, ashwagandha extracts were characterized to determine authenticity and to guide the necessary toxicological studies. To ensure the full constituency of the extracts are evaluated, a multi-detector system (UHPLC-PDA-CAD-HRMS) was employed and subjected to a comprehensive chemical constituent identification (CCID) process. All of the constituents above a threshold of toxicological concern (TTC) were quantified and identified. Identification was performed using HRMS and comparing fragmentation data to standards, literature, and/or online databases. These identifications were used to provide data for an in silico safety assessment. These data guide or obviate the need for classical in vitro and in vivo safety studies.

Publication Date

April 2024

Accessibility Status

Searchable text

Share

COinS
 
Apr 15th, 1:30 PM Apr 15th, 1:45 PM

Characterization of Ashwagandha Using a Multi-Detector Approach

Oxford Convention Center, 102 Ed Perry Boulevard Oxford, MS 38655

Botanicals are complex mixtures that present unique analytical challenges. A multi-detector chromatographic approach can provide accurate, constituent-based data to ensure proper identification and quantification of botanicals. These data are often used to help drive in silico safety assessments to identify suspected toxicants and assess the potential for deleterious effects using structure activity relationships. To showcase this approach, ashwagandha extracts were characterized to determine authenticity and to guide the necessary toxicological studies. To ensure the full constituency of the extracts are evaluated, a multi-detector system (UHPLC-PDA-CAD-HRMS) was employed and subjected to a comprehensive chemical constituent identification (CCID) process. All of the constituents above a threshold of toxicological concern (TTC) were quantified and identified. Identification was performed using HRMS and comparing fragmentation data to standards, literature, and/or online databases. These identifications were used to provide data for an in silico safety assessment. These data guide or obviate the need for classical in vitro and in vivo safety studies.

https://egrove.olemiss.edu/icsb/2024_ICSB/Schedule/5